ARHGEF12 and ovarian carcinoma: Given the relatively high recurrence rate of ARHGEF12 mutations in GC and ovarian cancer, and its enrichment in signaling pathways related to GC with OM, we further investigated the functions of ARHGEF12 mutations in GC.